pocketful logo
Abbott India Ltd logo

Abbott India Ltd

NSE: ABBOTINDIA BSE: 500488

₹26460

(-0.75%)

Sat, 14 Feb 2026, 11:57 am

mtf coin illustrationMTF 5x

Abbott India Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    56248.64

  • Net Profit

    1414.44

  • P/B

    15.43

  • Sector P/E

    39.96

  • P/E

    46.17

  • EV/EBITDA

    32.42

  • Debt/Equity (Industry)

    0.08

  • Interest Cover (Industry)

    146.92

  • ROCE (Industry)

    20.66

  • RONW (Industry)

    16.60

  • ROE

    37.86

  • ROCE

    54.90

  • Debt/Equity

    0.02

  • EPS (TTM)

    710.09

  • Dividend Yield

    1.79

  • Book Value

    1887.49

  • Interest Cover

    655

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (2.6x coverage).
  • Dividends per share have been stable in the past 10 years.
  • Abbott India's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Abbott India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
thumbs up icon

Cons

  • Abbott India's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • The average tenure for the Abbott India board of directors is less than 3 years, this suggests a new board.
  • Abbott India is not covered by any analysts.
  • Abbott India's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters74.9974.9974.9974.9974.99
FII0.180.160.160.160.16
DII9.009.119.198.929.01
Public15.8315.7515.6615.9315.84
Government00000

Read More

Technical Analysis

RSI

35.41

MACD

-343.10

50 DMA

27883.40

200 DMA

30509.10

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic32781.6730221.6728893.3327661.6726333.3325101.6722541.67
Fibonacci30221.6729243.7528639.5927661.6726683.7526079.5925101.67
Camarilla2826928034.3327799.6727661.6727330.3327095.6726861

Pivots Level: Classic

R3

+5120.00

32781.67

R2

+2560

30221.67

R1

+1231.67

28893.33

27661.67
27661.67
Pivot Point
LTP: 26460

S1

-1328.33

26333.33

S2

-2560

25101.67

S3

-5120

22541.67

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    27022.77

  • 20-EMA

    27286.78

  • 30-EMA

    27511.78

  • 50-EMA

    27920.10

  • 100-EMA

    28756.44

  • 200-EMA

    29425.22

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 Feb 2026board-meetingsQuarterly Results, Nine Months Results
06 Nov 2025board-meetingsQuarterly Results
15 May 2025agm
15 May 2025dividend₹475.00 Dividend /Share25 Jul 2025
09 May 2024dividend₹410.00 Dividend /Share19 Jul 2024
09 May 2024agm
19 May 2023agm
19 May 2023dividend₹180.00 Dividend /Share21 Jul 2023
17 May 2022dividend₹145.00 Dividend /Share04 Aug 2022
17 May 2022agm

Read More

Peer Comparison

Abbott India Ltd logo

Abbott India Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Abbott India Ltd About

Abbott India is leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.

Industry

Pharmaceuticals - Multinational

Founded

1944

Headquarters

CEO

Munir Shaikh

Employees

Contact

Website icon

Website

http://www.abbott.co.in

Email icon

Email

investorrelations.india@abbott.com; webmaster@abbo

Phone icon

Phone

91-22-67978888/50461000/2000/1119

Location icon

Location

Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra, 400071

Read More

Abbott India Ltd Company History

YearHistory
2021
  • Launched Pandemic Defense Coalition.
  • Launched Brufen Power spray.
  • Launched device for treatment of premature babies and newborns with heart openings.
  • Launched new Pediasure for catch-up growth in children.
2022
  • Announced collaborations for holistic diabetes care.
  • Launched Arachitol Gummies for Vitamin D and Calcium.
  • Launched Grow Right 2.0 for child growth.
  • Launched Ensure with HMB for muscle protection and strength.
  • Launched Navitor TAVI system for aortic stenosis.
2023
  • Launched Vertigo Coach app.
  • Launched Pediasure with Nutri-Pull system.
  • Launched vascular imaging platform powered by Ultreon 1.0 Software.
  • Launched XIENCE Sierra Everolimus Eluting Coronary Stent System.
2024
  • Launched next-generation Xience Sierra stent.
  • Launched GLP systems Track automation solutions.
  • Inaugurated innovative outreach centers with Yrgcare.
  • Launched Aveir Vr leadless pacemaker system.
2025
  • Launched new advanced formulation of Ensure Diabetes Care.
  • Launched AVEIR dual chamber leadless pacemaker system.
  • Introduced lab-based blood test to evaluate concussion.
  • Launched next-gen Freestyle Libre 2 Plus with continuous glucose readings and alarms.
  • Introduced Navitor Vision in India for aortic stenosis.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
No Result Found

Read More

Abbott India Ltd News

Abbott India Board Meet Set for Feb 12 Q3FY26 Results

Abbott India Limited has scheduled its Board of Directors meeting for February 12, 2026, to consider and approve unaudited financial results for Q3FY26 and nine months ended December 31, 2025.

04 Feb 2026

co actions results

ABB India Block Trade Worth Rs. 69.64 Crores

ABB India executed a significant block trade on NSE worth Rs. 69.64 crores involving 121,882 shares at Rs. 5713.50 per share, indicating substantial institutional activity.

03 Feb 2026

co actions results

ABB India Shows Bullish Technical Reversal Pattern

ABB India exhibits double bottom pattern breakout above ₹4,750 resistance with technical indicators confirming bullish momentum despite recent declines of 7.90% monthly and 24.02% yearly.

23 Jan 2026

stocks

Abbott shares drop 8% on Q4 revenue miss, weak Q1 outlook

Abbott Laboratories stock fell over 8% after missing Q4 revenue targets at $11.5 billion versus $11.8 billion expected and forecasting Q1 earnings below Wall Street estimates at $1.12-$1.18 per share.

22 Jan 2026

global

ABB targets higher India revenue share before 2030

ABB CEO Morten Wierod announces plans to increase India's contribution to global revenues and elevate it from fourth to third-largest market position before 2030, citing strong order book and energy expansion opportunities.

21 Jan 2026

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800